New PET technologies - embracing progress and pushing the limits
Eur J Nucl Med Mol Imaging
.
2021 Aug;48(9):2711-2726.
doi: 10.1007/s00259-021-05390-4.
Epub 2021 Jun 3.
Authors
Nicolas Aide
1
2
,
Charline Lasnon
3
4
,
Adam Kesner
5
,
Craig S Levin
6
,
Irene Buvat
7
,
Andrei Iagaru
8
,
Ken Hermann
9
,
Ramsey D Badawi
10
,
Simon R Cherry
10
,
Kevin M Bradley
11
,
Daniel R McGowan
12
13
Affiliations
1
Nuclear medicine Department, University Hospital, Caen, France. aide-n@chu-caen.fr.
2
INSERM ANTICIPE, Normandie University, Caen, France. aide-n@chu-caen.fr.
3
INSERM ANTICIPE, Normandie University, Caen, France.
4
François Baclesse Cancer Centre, Caen, France.
5
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
6
Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA, 94305, USA.
7
Institut Curie, Université PLS, Inserm, U1288 LITO, Orsay, France.
8
Department of Radiology, Division of Nuclear Medicine and Molecular Imaging, Stanford University, Stanford, CA, 94305, USA.
9
Department of Nuclear Medicine, University of Duisburg-Essen and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
10
Departments of Radiology and Biomedical Engineering, University of California, Davis, CA, USA.
11
Wales Research and Diagnostic PET Imaging Centre, Cardiff University, Cardiff, UK.
12
Radiation Physics and Protection, Churchill Hospital, Oxford University Hospitals NHS FT, Oxford, UK. daniel.mcgowan@oncology.ox.ac.uk.
13
Department of Oncology, University of Oxford, Oxford, UK. daniel.mcgowan@oncology.ox.ac.uk.
PMID:
34081153
PMCID:
PMC8263417
DOI:
10.1007/s00259-021-05390-4
No abstract available
Publication types
Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
MeSH terms
Humans
Positron-Emission Tomography*
Grants and funding
U01CA21002003/CA/NCI NIH HHS/United States
P30 CA093373/CA/NCI NIH HHS/United States
28684/CRUK_/Cancer Research UK/United Kingdom
C34326/A28684/CRUK_/Cancer Research UK/United Kingdom
C4278/A27066/CRUK_/Cancer Research UK/United Kingdom
R01CA23043801A1/CA/NCI NIH HHS/United States